News
Media
Conference
Publications
Resources
Partners
Subscribe

Spotlight -

Geographic Atrophy

Eric B. Suhler, MD, MPH

Articles by Eric B. Suhler, MD, MPH

Adalimumab therapy safe, effective in real-world, open-label uveitis study

ByFred Gebhart,Eric B. Suhler, MD, MPH

May 1st 2018

Latest Updated Articles

Adalimumab therapy safe, effective in real-world, open-label uveitis study
May 1st 2018

Trending on Modern Retina

Johnson & Johnson’s TECNIS PureSee EDOF IOL cleared for US market

Ocugen completes enrollment in liMeliGhT phase 3 trial of OCU400 for retinitis pigmentosa

Eichenbaum Acorns: Collaborative retina care with Jeffry D. Gerson, OD, FAAO

Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation

FDA clears phase I/II trial of SVT-001 cell therapy for familial drusen–associated vision loss